Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

No studies found 2 · 66.7%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 33.3%Moderate 0 · 0%High 0 · 0%

> 50% increase in SCr · people IgA nephropathy

Renin‐angiotensin system inhibition may leads to lower > 50% increase in SCr compared with other supportive care treatment (low certainty).

1 finding from 1 review

Non‐immunosuppressive treatment for IgA nephropathy 2024 · Cochrane Headline outcomes only
RR 0.23 [0.07, 0.7]
1 study · 44 participants
Low

> 50% increase in SCr · people IgA nephropathy

The review found no eligible studies for this question.

1 finding from 1 review

Non‐immunosuppressive treatment for IgA nephropathy 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

> 50% increase in SCr · people IgA nephropathy

The review found no eligible studies for this question.

1 finding from 1 review

Non‐immunosuppressive treatment for IgA nephropathy 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found